In this podcast, we speak to Dr Brian Ference, a cardiologist and genetic epidemiologist from Cambridge University in the United Kingdom. Dr Ference designs Mendelian randomisation studies to help answer some of the big questions in cardiology, including: what magnitude of benefit could we achieve with earlier, sustained low levels of LDL-cholesterol on lifetime risk of ...
Podcast: Dr Brian Ference on early lowering of LDL-C levels and CV risk
4 Apr 2019
Sponsored by Amgen Australia Pty Ltd